Q4 2021 Holdings
Filed 2022-02-11 | 55 holdings | $25.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $403.0K | 100,759 | 1.6% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $3.9M | 100,000 | 15.3% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $5.8M | 400,000 | 23.1% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $6.6M | 145,552 | 26.3% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $8.2M | 494,046 | 32.7% |